Abstract:Normal liver dose is of paramount in liver SBRT due to the risk of radiation induced liver disease (RILD). In our clinic, the generalized equivalent uniform dose (gEUD) of normal liver (liver-GTV) is used to determine if a prescription (Rx) needs to be deescalated (e.g., from 50 to 45 Gy) to limit the risk of RILD. To estimate the normal liver gEUD, a planner often needs to create a preliminary plan with full Rx. The goal of this work was to build a machine learning model using artificial neural network trained with our prior SBRT patients to predict normal liver gEUD purely using the geometric properties of liver and PTV, to eliminate the need for the preliminary plan. The initial model was trained by 40 consecutive liver SBRT patients treated in our clinic from December 2014 to February 2018 meeting the following criteria: (1) 50 Gy in 5 or 6 fractions, (2) single-lesion IMRT or VMAT plan created using multi-criteria optimization (MCO), (3) no prior radiation or no dosimetric impact from any prior radiation, and (4) 98% of GTV covered by >50 Gy. An A value of 0.9 was used to calculate the gEUD of normal liver (excluding GTV). The artificial neural network consisted of five layers including three hidden ones. It used six inputs: the x, y, and z coordinate of the center of PTV relative to the center of total liver (including GTV), the distance between the two centers, and the volume of the PTV and total liver. The model was tested on new consecutive patients since February 2018. Since the model is bounded to input ranges, a new patient with input outside the initial range cannot be used test the model. For this reason, five new patients were added to the learning data before ten qualified new patients were found to test the model. All training and test patients were treated on two different linear accelerators, both with 5-mm leaves in central 20×20 cm2 field. The model accurately predicted normal liver gEUD for five patients, with an error of <3.2% (<0.35 Gy). For the other five, the error ranged from 7.9% to 12.9% (0.76 to 1.33 Gy). On average, the error was -0.8±8.4% (-0.14±0.98 Gy). The error increased when any input approached the limit in the under-sampled boundary region. For the patient with the largest error, the x of PTV center was -7.23 cm, only 0.08 cm away from the lower limit. For the patient with the second largest error, the y of PTV center was 7.16 cm, only 0.75 cm away from the upper limit. The model will become more robust once it learns from those patients with inputs in the boundary regions. The calculation for a new patient takes <1 second on a regular PC. The model can be exported as a Python function and scripted in common contouring and planning systems. A machine learning model was built to predict normal liver gEUD in 50-Gy liver SBRT, only using the geometric properties of liver and PTV. The prediction was within 13% (1.3 Gy) of the actual value for ten consecutive prospective patients. The model can facilitate the Rx selection in liver SBRT, promoting efficiency for planners and clinicians.

Hubbard band versus oxygen vacancy states in the correlated electron metal SrVO3

A Machine-Learning Model Using Artificial Neural Network to Facilitate Liver SBRT Prescription Selection by Predicting Normal Liver Geud Based on Geometric Properties of Liver and PTV

Development and validation of a nomogram for radiation-induced hepatic toxicity after intensity modulated radiotherapy for hepatocellular carcinoma: a retrospective study

Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma

CT-based multimodal deep learning for non-invasive overall survival prediction in advanced hepatocellular carcinoma patients treated with immunotherapy

Deep Learning-Based Prediction of Post-treatment Survival in Hepatocellular Carcinoma Patients Using Pre-treatment CT Images and Clinical Data

Phospholipids in the tissues of the eye. II. Composition and incorporation of 32Pi of phospholipids of normal rat and calf lens.

Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy

Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors

Multilayered insights: a machine learning approach for personalized prognostic assessment in hepatocellular carcinoma

COLUMN CHROMATOPGRAPHY ON DEAE CELLULOSE COLUMN OF HERPES SIMPLEX VIRUS AND CYTOMEGALOVIRUS.

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

A New Prognostic Model for Radiation-Based Hepatocellular Carcinoma Treatment

Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma.

Prediction of Post-hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma Based on Radiomics Using Gd-EOB-DTPA-Enhanced MRI: the Liver Failure Model

Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy

A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma

A deep learning model for personalized intra-arterial therapy planning in unresectable hepatocellular carcinoma: a multicenter retrospective study

Multiparametric MRI-based Machine Learning Radiomics for Predicting Treatment Response to Transarterial Chemoembolization Combined with Targeted and Immunotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Study

Effects of acid stress on polyamine levels, ion efflux, protective enzymes and macromolecular synthesis in cereal leaves